During the last session, Applied Dna Sciences Inc (NASDAQ:APDN)’s traded shares were 1.2 million, with the beta value of the company hitting 0.17. At the end of the trading day, the stock’s price was $0.24, reflecting an intraday loss of -17.66% or -$0.05. The 52-week high for the APDN share is $1.86, that puts it down -675.0 from that peak though still a striking -16.67% loss since the share price plummeted to a 52-week low of $0.28. The company’s market capitalization is $4.05M, and the average trade volume was 135.50K shares over the past three months.
Applied Dna Sciences Inc (NASDAQ:APDN) trade information
Applied Dna Sciences Inc (APDN) registered a -17.66% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -17.66% in intraday trading to $0.24, hitting a weekly high. The stock’s 5-day price performance is -28.29%, and it has moved by -50.25% in 30 days. Based on these gigs, the overall price performance for the year is -77.04%.
Applied Dna Sciences Inc (APDN) estimates and forecasts
Statistics show that Applied Dna Sciences Inc has underperformed its competitors in share price, compared to the industry in which it operates. Applied Dna Sciences Inc (APDN) shares have gone down -70.81% during the last six months, with a year-to-date growth rate less than the industry average at 17.11% against 22.20. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to shrink -540.00% this quarter and then jump 25.00% in the quarter after that. In the rating firms’ projections, revenue will decrease -62.40% compared to the previous financial year.
Revenue for the current quarter is expected to be $950k as predicted by 2 analyst(s). Meanwhile, a consensus of 2 analyst(s) estimates revenue growth to $1.18 million by the end of Jun 2024.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 45.52%. While earnings are projected to return 14.47% in 2024.
APDN Dividends
Applied Dna Sciences Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
